A citation-based method for searching scientific literature

James L Frazier, Paul P Wang, Daniel Case, Betty M Tyler, Gustavo Pradilla, Jon D Weingart, Henry Brem. J Neurooncol 2003
Times Cited: 32







List of co-cited articles
387 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The role of minocycline in the treatment of intracranial 9L glioma.
J D Weingart, E P Sipos, H Brem. J Neurosurg 1995
63
40

Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.
Hansen Bow, Lee S Hwang, Noam Schildhaus, Joanna Xing, Luke Murray, Quinn Salditch, Xiaobu Ye, Yonggang Zhang, Jon Weingart, Henry Brem,[...]. J Neurosurg 2014
25
40

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Manfred Westphal, Dana C Hilt, Enoch Bortey, Patrick Delavault, Robert Olivares, Peter C Warnke, Ian R Whittle, Juha Jääskeläinen, Zvi Ram. Neuro Oncol 2003
873
25


Targeted therapy for brain tumours.
Maciej S Lesniak, Henry Brem. Nat Rev Drug Discov 2004
144
21

Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy.
Phillip B Storm, John L Moriarity, Betty Tyler, Peter C Burger, Henry Brem, Jon Weingart. J Neurooncol 2002
74
21

Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
K A Walter, M A Cahan, A Gur, B Tyler, J Hilton, O M Colvin, P C Burger, A Domb, H Brem. Cancer Res 1994
167
21

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study.
S Valtonen, U Timonen, P Toivanen, H Kalimo, L Kivipelto, O Heiskanen, G Unsgaard, T Kuurne. Neurosurgery 1997
317
21

Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.
R J Tamargo, J S Myseros, J I Epstein, M B Yang, M Chasin, H Brem. Cancer Res 1993
166
21

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
21

Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
Alessandro Olivi, Stuart A Grossman, Stephen Tatter, Fred Barker, Kevin Judy, Jeffrey Olsen, Jeffrey Bruce, Dana Hilt, Joy Fisher, Steve Piantadosi. J Clin Oncol 2003
67
18

Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.
A Olivi, M G Ewend, T Utsuki, B Tyler, A J Domb, D J Brat, H Brem. Cancer Chemother Pharmacol 1996
66
18

Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats.
Francesco DiMeco, Khan W Li, Berry M Tyler, Ariel S Wolf, Henry Brem, Alessandro Olivi. J Neurosurg 2002
41
18

Angiogenesis inhibition by minocycline.
R J Tamargo, R A Bok, H Brem. Cancer Res 1991
223
18

The role of microglia and macrophages in glioma maintenance and progression.
Dolores Hambardzumyan, David H Gutmann, Helmut Kettenmann. Nat Neurosci 2016
792
18

Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
E P Sipos, B Tyler, S Piantadosi, P C Burger, H Brem. Cancer Chemother Pharmacol 1997
85
15

O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
L D Rhines, P Sampath, M E Dolan, B M Tyler, H Brem, J Weingart. Cancer Res 2000
56
15

Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
K D Judy, A Olivi, K G Buahin, A Domb, J I Epstein, O M Colvin, H Brem. J Neurosurg 1995
66
15

Brain biocompatibility of a biodegradable, controlled-release polymer in rats.
R J Tamargo, J I Epstein, C S Reinhard, M Chasin, H Brem. J Biomed Mater Res 1989
104
15

Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.
L K Fung, M G Ewend, A Sills, E P Sipos, R Thompson, M Watts, O M Colvin, H Brem, W M Saltzman. Cancer Res 1998
193
15

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.
H Brem, M S Mahaley, N A Vick, K L Black, S C Schold, P C Burger, A H Friedman, I S Ciric, T W Eller, J W Cozzens. J Neurosurg 1991
351
15

Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
H Brem, R J Tamargo, A Olivi, M Pinn, J D Weingart, M Wharam, J I Epstein. J Neurosurg 1994
101
12

Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
P Sampath, J Hanes, F DiMeco, B M Tyler, D Brat, D M Pardoll, H Brem. Cancer Res 1999
44
12


Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
Laurence D Rhines, Prakash Sampath, Francesco DiMeco, H Christopher Lawson, Betty M Tyler, Justin Hanes, Alessandro Olivi, Henry Brem. Neurosurgery 2003
53
12

Convection-enhanced delivery of macromolecules in the brain.
R H Bobo, D W Laske, A Akbasak, P F Morrison, R L Dedrick, E H Oldfield. Proc Natl Acad Sci U S A 1994
12


Pharmacokinetics of the carmustine implant.
Alison B Fleming, W Mark Saltzman. Clin Pharmacokinet 2002
188
12

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
12


Immunohistological study of mononuclear cell infiltrate in malignant gliomas.
M L Rossi, J T Hughes, M M Esiri, H B Coakham, D B Brownell. Acta Neuropathol 1987
162
12

Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial.
Philippe Menei, Laurent Capelle, Jacques Guyotat, Stéphane Fuentes, Richard Assaker, Benoit Bataille, Patrick François, Didier Dorwling-Carter, Philippe Paquis, Luc Bauchet,[...]. Neurosurgery 2005
71
12

Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
M Westphal, Z Ram, V Riddle, D Hilt, E Bortey. Acta Neurochir (Wien) 2006
284
12

Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model.
Ananth K Vellimana, Violette Renard Recinos, Lee Hwang, Kirk D Fowers, Khan W Li, Yonggang Zhang, Saint Okonma, Charles G Eberhart, Henry Brem, Betty M Tyler. J Neurooncol 2013
54
12

Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression.
D S Markovic, K Vinnakota, N van Rooijen, J Kiwit, M Synowitz, R Glass, H Kettenmann. Brain Behav Immun 2011
75
12

Gliadel wafers in the treatment of malignant glioma: a systematic review.
J Perry, A Chambers, K Spithoff, N Laperriere. Curr Oncol 2007
110
12

Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
Frank Szulzewsky, Andreas Pelz, Xi Feng, Michael Synowitz, Darko Markovic, Thomas Langmann, Inge R Holtman, Xi Wang, Bart J L Eggen, Hendrikus W G M Boddeke,[...]. PLoS One 2015
252
12

Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.
Wenchao Zhou, Susan Q Ke, Zhi Huang, William Flavahan, Xiaoguang Fang, Jeremy Paul, Ling Wu, Andrew E Sloan, Roger E McLendon, Xiaoxia Li,[...]. Nat Cell Biol 2015
511
12

CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Stephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, Robert L Bowman, Lisa Sevenich, Daniela F Quail, Oakley C Olson, Marsha L Quick, Jason T Huse, Virginia Teijeiro,[...]. Nat Med 2013
12


Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Xi Feng, Frank Szulzewsky, Alexan Yerevanian, Zhihong Chen, David Heinzmann, Rikke Darling Rasmussen, Virginia Alvarez-Garcia, Yeonghwan Kim, Bingcheng Wang, Ilaria Tamagno,[...]. Oncotarget 2015
122
12

Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma.
Robert T Wicks, Javad Azadi, Antonella Mangraviti, Irma Zhang, Lee Hwang, Avadhut Joshi, Hansen Bow, Marianne Hutt-Cabezas, Kristin L Martin, Michelle A Rudek,[...]. Neuro Oncol 2015
36
12

Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers.
Jesse B Wolinsky, Yolonda L Colson, Mark W Grinstaff. J Control Release 2012
454
12

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
M D Walker, S B Green, D P Byar, E Alexander, U Batzdorf, W H Brooks, W E Hunt, C S MacCarty, M S Mahaley, J Mealey,[...]. N Engl J Med 1980
9

Chemotherapy for malignant gliomas.
P L Kornblith, M Walker. J Neurosurg 1988
283
9

Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.
H Brem, A Kader, J I Epstein, R J Tamargo, A Domb, R Langer, K W Leong. Sel Cancer Ther 1989
80
9

Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors.
A J Domb, Z H Israel, O Elmalak, D Teomim, A Bentolila. Pharm Res 1999
36
9



Biocompatibility of polymeric delivery systems for macromolecules.
R Langer, H Brem, D Tapper. J Biomed Mater Res 1981
75
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.